TSXV:LBL.H - Post by User
Comment by
colimaon Mar 28, 2020 1:00am
146 Views
Post# 30855379
RE:RE:Update....?
RE:RE:Update....?Individuals enrolled into the investigational group will receive ~ 5 million stem cells of AmnioBoost on the first day of enrollment and will receive another ~ 5 million stem cells on the second day of enrollment. Clinicians will monitor the patients temperature, blood pressure, need for supplemental oxygen, and other factors daily to determine daily scores based on a scale of clinical outcomes. In the initial stage of investigation, the clinicians will compare participant outcomes on day seven in both groups to assess if AmnioBoost treatment has produced any clinical benefit. The study will be halted if there is no evidence of a treatment difference between AmnioBoost and placebo.